Creutzfeldt - Jakob Disease from Prions to Neurodegeneration
Received Date: Sep 02, 2023 / Published Date: Sep 28, 2023
Abstract
Dementia is a progressive neurodegenerative disorder that affects millions of people worldwide, causing cognitive decline, memory loss, and behavioral changes. While there is no cure for dementia, pharmacological treatments aim to manage symptoms and slow down disease progression. This article provides an overview of the current pharmacological options, including cholinesterase inhibitors and NMDA receptor antagonists, commonly used in dementia treatment. Additionally, it explores emerging therapies, such as anti-amyloid therapies, tau protein stabilizers, anti-inflammatory drugs, and neuroprotective agents, which hold promise for modifying the underlying pathology of dementia. Continued research in pharmacological interventions is crucial for developing more effective treatments and improving the lives of individuals affected by dementia.
Citation: Gonda K (2023) Creutzfeldt - Jakob Disease from Prions to Neurodegeneration. J Dement 7: 173. Doi: 10.4172/dementia.1000173
Copyright: © 2023 Gonda K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Conferences
42nd Global Conference on Nursing Care & Patient Safety
Toronto, CanadaRecommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 567
- [From(publication date): 0-2023 - Feb 23, 2025]
- Breakdown by view type
- HTML page views: 482
- PDF downloads: 85